Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients

被引：0
|
作者：
Andrea Sacconi
Paola Muti
Claudio Pulito
Giulia Urbani
Matteo Allegretti
Raul Pellini
Nikolay Mehterov
Uri Ben-David
Sabrina Strano
Paolo Bossi
Giovanni Blandino
机构：
[1] Clinical Trial Center,Department of Biomedical
[2] Biostatistics and Bioinformatics,Translational Oncology Research Unit
[3] IRCCS Regina Elena National Cancer Institute,Department of Medical Biology
[4] Surgical Science and Oral Health,Research Institute
[5] Milan University,Department of Human Molecular Genetics and Biochemistry
[6] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Department of Biomedical Sciences
[7] Maxillo-Facial Surgery and Dental Unit,undefined
[8] IRCCS Regina Elena National Cancer Institute,undefined
[9] Otolaryngology Head and Neck Surgery Unit,undefined
[10] IRCCS Regina Elena National Cancer Institute,undefined
[11] Medical University-Plovdiv,undefined
[12] Medical University-Plovdiv,undefined
[13] Faculty of Medicine,undefined
[14] Tel Aviv University,undefined
[15] SAFU Unit,undefined
[16] IRCCS Regina Elena National Cancer Institute,undefined
[17] Humanitas University,undefined
[18] IRCCS Humanitas Research Hospital,undefined
来源：
Molecular Cancer | / 22卷
关键词：
HNSCC; Immunotherapy; Immune checkpoint inhibitor; p53; PDL1; c-MYC; PI3K;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
    Sacconi, Andrea
    Muti, Paola
    Pulito, Claudio
    Urbani, Giulia
    Allegretti, Matteo
    Pellini, Raul
    Mehterov, Nikolay
    Ben-David, Uri
    Strano, Sabrina
    Bossi, Paolo
    Blandino, Giovanni
    MOLECULAR CANCER, 2023, 22 (01)
  • [2] TP53 mutations in head and neck cancer
    Beutner, Dirk
    Klussmann, Jens-Peter
    Guntinas-Lichius, Orlando
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1194 - 1194
  • [3] TP53 mutations in head and neck cancer
    Nathan, Cherie-Ann
    Khandelwal, Alok R.
    Wolf, Gregory T.
    Rodrigo, Juan P.
    Makitie, Antti A.
    Saba, Nabil F.
    Forastiere, Arlene A.
    Bradford, Carol R.
    Ferlito, Alfio
    MOLECULAR CARCINOGENESIS, 2022, 61 (04) : 385 - 391
  • [4] TP53 mutations in head and neck cancer -: Reply
    Koch, Wayne
    Poeta, M. Luana
    Manola, Judith
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1195 - 1195
  • [5] Stability of rare TP53 co-mutations in AML patients.
    Bloom, Kenneth Joel
    Idica, Adam
    Smart, Dave
    Allen, Wendy
    Scanlon, Enya
    Clark, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] The role of PTEN and TP53 co-mutations in immunotherapy of lung cancer.
    Ma, Xiaolong
    Zhang, Ding
    Chen, Shiqing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] TP53 mutation is associated with poor survival in patients with head and neck cancer
    Nature Clinical Practice Oncology, 2008, 5 (4): : 180 - 180
  • [8] A Pan-Cancer Assessment of RB1/TP53 Co-Mutations
    Cai, Ling
    DeBerardinis, Ralph J.
    Xiao, Guanghua
    Minna, John D.
    Xie, Yang
    CANCERS, 2022, 14 (17)
  • [9] Relations between mutant KRAS and TP53 subtypes and other co-mutations in pancreatic cancer
    Abraham, Soniya
    Zhang, Janie Yue
    Walther, Zenta
    Parekh, Jay
    Lacy, Jill
    Cecchini, Michael
    Hu, Yiduo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Targeting the Chemoradiation Resistance of Lung Cancers with KRAS/TP53 Co-Mutations
    Willers, H.
    Gurtner, K.
    Benes, C.
    Baumann, M.
    Krause, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1138 - S1139
12345